Hemostemix Adds the Treatment of Refractory Angina to Its Phase 1 Basket Protocol

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company ...

Powell Paves The Way For A Year-End Rally

Strong earnings, Fed stimulus, and resilient consumers signal continued S&P 500 growth. Click here to read what investors ...